Baird Reiterates Outperform Rating on Alto Neuroscience (ANRO)
Tweet Send to a Friend
Baird analyst Brian Skorney reiterated an Outperform rating and $32.00 price target on Alto Neuroscience (NYSE: ANRO).The analyst commented: "Incrementally ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


